Apr 17, 2019 8:00am EDT Avalon GloboCare to Host The 3rd Annual International Scientific Forum on Exosome Research and Application (ISFERA) in Beijing on July 19, 2019
Apr 08, 2019 8:35am EDT Avalon GloboCare Appoints Finance Veteran Yue ''Charles'' Li to the Board of Directors
Mar 06, 2019 8:00am EST Avalon GloboCare to Present at the 31st Annual ROTH Conference on March 17-19, 2019
Feb 26, 2019 8:00am EST Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy
Feb 11, 2019 8:30am EST Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells
Feb 04, 2019 8:15am EST Avalon GloboCare CEO David Jin, M.D., Ph.D. to Co-Chair the “Status of Cellular Therapy in the Asia Pacific Rim” Session at the Annual Meetings of the Transplantation and Cellular Therapy (TCT) -- ASBMT and CIBMTR Tandem Meeting 2019
Jan 28, 2019 8:00am EST Avalon GloboCare and its Subsidiary Genexosome Technologies Announce Discovery and Development of World’s First Saliva-Based Exosomal Biomarker “miR-185” as Dual Diagnostic and Therapeutic Target for Oral Cancer
Jan 15, 2019 8:00am EST Avalon GloboCare CEO David Jin, M.D., Ph.D. to Chair and Speak at the Plenary Session of the 14th Annual World Stem Cell Summit
Jan 03, 2019 9:00am EST Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
Dec 19, 2018 8:00am EST Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern